Precoccious puberty during outpatient pamidronate therapy in type I Osteogenesis Imperfecta.

被引:0
|
作者
Markello, TC
Boston, R
Steiner, R
机构
[1] Samaritan Hlth Serv, Dept Pediat, Lebanon, OR USA
[2] Oregon Hlth Sci Univ, Portland, OR 97201 USA
关键词
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
2400
引用
收藏
页码:579 / 579
页数:1
相关论文
共 50 条
  • [31] Responsiveness to pamidronate treatment is not related to the genotype of type I collagen in patients with osteogenesis imperfecta
    Junko Kanno
    Akiko Saito-Hakoda
    Shigeo Kure
    Ikuma Fujiwara
    Journal of Bone and Mineral Metabolism, 2018, 36 : 344 - 351
  • [32] The clinical, molecular and histological heterogeneity of type IV osteogenesis imperfecta.
    Ward, LM
    Lalic, L
    Lalic, R
    Roughley, P
    Rauch, F
    Plotkin, H
    Travers, R
    Glorieux, FH
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S163 - S163
  • [33] Gene therapy strategy to improve bone quality in osteogenesis imperfecta.
    King, D
    Beamer, W
    Chase, J
    Havey, R
    Patwardhan, A
    Saban, J
    Schneider, G
    Sparks, SE
    Steinke, B
    Zussman, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : S527 - S527
  • [34] Mutation-independent gene therapy strategy for osteogenesis imperfecta.
    McMahon, HP
    Allen, D
    Humphries, P
    Kenna, PF
    Millington-Ward, S
    Farrar, GJ
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 622 - 622
  • [35] Cell-specific processing of mutant type I collagen in three probands with Osteogenesis imperfecta.
    Cabral, WA
    Marini, JC
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A287 - A287
  • [36] Pamidronate therapy in children with osteogenesis imperfecta and idiopathic juvenile osteoporosis
    Carr, RR
    Robinson, RF
    Mahan, JD
    Nahata, MC
    PHARMACOTHERAPY, 2004, 24 (10): : 1454 - 1454
  • [37] Cyclic intravenous pamidronate for an infant with osteogenesis imperfecta type II
    Fukahori, Kyoko
    Nirei, Jun
    Yamawaki, Kaoru
    Nagasaki, Keisuke
    BMJ CASE REPORTS, 2023, 16 (05)
  • [38] Gain in BMD and grip strength after one year of pamidronate treatment in 132 children with osteogenesis imperfecta.
    Plotkin, H
    Montpetit, K
    Cloutier, S
    Bilodeau, N
    Gervais, N
    Rabzel, M
    Travers, R
    Glorieux, FH
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S484 - S484
  • [39] Cyclic pamidronate in children with osteogenesis imperfecta.: Review of a protocol of a single-day infusion twice a year
    Antón, J
    Ricart, S
    Ros, J
    Gonzalez-Pascual, E
    Villaronga, M
    Huguet, R
    Pou, J
    BONE, 2005, 36 : S82 - S82
  • [40] Osteogenesis imperfecta types I, III, and IV: Effect of pamidronate therapy on bone and mineral metabolism
    Rauch, F
    Plotkin, H
    Travers, R
    Zeitlin, L
    Glorieux, FH
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (03): : 986 - 992